Allogeneic Murine Mesenchymal Stem Cells: Migration to Inflamed Joints In Vivo and Amelioration of Collagen Induced Arthritis When Transduced to Express CTLA4Ig

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Stem Cells and Development

• Publication date

  2013-07-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/scd.2013.0248PMID 23895495PMCID PMC3868391
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Homing of mesenchymal stem cells: mechanistic or stochastic? Implications for targeted delivery in arthritis.

  2015cited by this paper
• Viral vector-mediated transgenic cell therapy in regenerative medicine: safety of the process

  2015cited by this paper
• Emerging immunotherapies for rheumatoid arthritis

  2014cited by this paper
• Mesenchymal Stem Cell-Based Treatment for Microvascular and Secondary Complications of Diabetes Mellitus

  2014cited by this paper
• Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis

  2012influential reference
• Mesenchymal Stem Cells Transmigrate Between and Directly Through Tumor Necrosis Factor‐α‐Activated Endothelial Cells Via Both Leukocyte‐Like and Novel Mechanisms

  2012cited by this paper
• The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model

  2012cited by this paper
• Adenoviral Transduction of Mesenchymal Stem Cells: In Vitro Responses and In Vivo Immune Responses after Cell Transplantation

  2012cited by this paper
• Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: contribution to the chronicity of rheumatoid arthritis.

  2012cited by this paper
• Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis.

  2012cited by this paper
• Genetic mismatch affects the immunosuppressive properties of mesenchymal stem cells in vitro and their ability to influence the course of collagen-induced arthritis

  2012cited by this paper
• Transforming growth factor β-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis.

  2011cited by this paper
• Mesenchymal stem cell inhibition of T‐helper 17 cell‐ differentiation is triggered by cell–cell contact and mediated by prostaglandin E2 via the EP4 receptor

  2011cited by this paper
• Human umbilical blood mononuclear cell–derived mesenchymal stem cells serve as interleukin‐21 gene delivery vehicles for epithelial ovarian cancer therapy in nude mice

  2011cited by this paper
• Collagen-induced arthritis and related animal models: how much of their pathogenesis is auto-immune, how much is auto-inflammatory?

  2011cited by this paper
• Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis

  2011cited by this paper
• Transplantation of CTLA4Ig gene‐transduced adipose tissue‐derived mesenchymal stem cells reduces inflammatory immune response and improves Th1/Th2 balance in experimental autoimmune thyroiditis

  2011cited by this paper
• Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth.

  2011cited by this paper
• Stem cell based cancer gene therapy.

  2011cited by this paper
• Development of TNF inhibitor therapies for the treatment of rheumatoid arthritis.

  2010cited by this paper
• Circulating plastic adherent mesenchymal stem cells in aged hip fracture patients

  2010cited by this paper
• Immunosuppressive effects of mesenchymal stem cells in collagen-induced mouse arthritis

  2010cited by this paper
• Flk‐1+ mesenchymal stem cells aggravate collagen‐induced arthritis by up‐regulating interleukin‐6

  2010cited by this paper
• Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis

  2010cited by this paper
• Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis

  2010cited by this paper
• Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles.

  2009cited by this paper
• Alterations in Cytokine Profile and Dendritic Cells Subsets in Peripheral Blood of Rheumatoid Arthritis Patients before and after Biologic Therapy

  2009cited by this paper
• Fibrogenic Potential of Human Multipotent Mesenchymal Stromal Cells in Injured Liver

  2009cited by this paper
• The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.

  2009cited by this paper
• Mesenchymal stem cell homing: the devil is in the details.

  2009cited by this paper
• Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.

  2009cited by this paper
• Mesenchymal stem cells overexpressing interleukin‐10 attenuate collagen‐induced arthritis in mice

  2008cited by this paper
• Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.

  2008cited by this paper
• Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation.

  2008cited by this paper
• Immunomodulatory and osteogenic differentiation effects of mesenchymal stem cells by adenovirus‐mediated coexpression of CTLA4Ig and BMP2

  2008cited by this paper
• B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.

  2007cited by this paper
• Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis.

  2007cited by this paper
• Late-Outgrowth Endothelial Cells Attenuate Intimal Hyperplasia Contributed by Mesenchymal Stem Cells After Vascular Injury

  2007cited by this paper
• Gene Transfer into Rat Mesenchymal Stem Cells: A Comparative Study of Viral and Nonviral Vectors

  2006cited by this paper
• An essential role of NF-κB in the “tumor-like” phenotype of arthritic synoviocytes

  2006cited by this paper
• Influence of local and systemic CTLA4Ig gene transfer on corneal allograft survival

  2006cited by this paper
• T-cell costimulation--biology, therapeutic potential, and challenges.

  2006cited by this paper
• Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.

  2005cited by this paper
• Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

  2005cited by this paper
• Human mesenchymal stem cells modulate allogeneic immune cell responses.

  2005cited by this paper
• Mesenchymal Stem Cells Inhibit the Expression of CD25 (Interleukin‐2 Receptor) and CD38 on Phytohaemagglutinin‐Activated Lymphocytes

  2004cited by this paper
• Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential.

  2004cited by this paper
• Mesenchymal stem cells: clinical applications and biological characterization.

  2004cited by this paper
• Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction.

  2004cited by this paper
• Efficiency of adenoviral vector mediated CTLA4Ig gene delivery into mesenchymal stem cells.

  2003cited by this paper
• Stem cell therapy in a caprine model of osteoarthritis.

  2003cited by this paper
• Veto-Like Activity of Mesenchymal Stem Cells: Functional Discrimination Between Cellular Responses to Alloantigens and Recall Antigens1

  2003cited by this paper
• Characterization and functionality of cell surface molecules on human mesenchymal stem cells.

  2003cited by this paper
• Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

  2003cited by this paper
• Evolving concepts of rheumatoid arthritis

  2003cited by this paper
• Polycythemia vera: myths, mechanisms, and management.

  2002influential reference
• Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis.

  2002cited by this paper
• Cytokine pathways and joint inflammation in rheumatoid arthritis.

  2001cited by this paper
• Mediators of inflammation and acute phase response in the liver.

  2001cited by this paper

• Advances in stem cell-based therapeutics for acute high-altitude illness: research progress and prospects

  2025cites this paper
• Cellular therapies in rheumatic and musculoskeletal diseases

  2024cites this paper
• Current Advances in Regenerative Medicine for Articular Cartilage Injury: Progress and Market Trends

  2023cites this paper
• Mesenchymal Stem Cell Therapy for Osteoarthritis: Practice and Possible Promises.

  2022cites this paper
• Comparison of biological characteristics of human adipose- and umbilical cord- derived mesenchymal stem cells and their effects on delaying the progression of osteoarthritis in a rat model.

  2022cites this paper
• Ultrasound imaging tracking of mesenchymal stem cells intracellularly labeled with biosynthetic gas vesicles for treatment of rheumatoid arthritis

  2022cites this paper
• TBHQ Regulates the Nrf2/HO-1 Pathway to Enhance Stem Cell Treatment of Diabetic Retinopathy

  2021cites this paper
• Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies

  2021cites this paper
• Mesenchymal stromal cells for articular cartilage repair: preclinical studies.

  2020cites this paper
• Comparative study between human mesenchymal stem cells and etanercept as immunomodulatory agents in rat model of rheumatoid arthritis

  2020cites this paper
• Concise Review: Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era?

  2019cites this paper
• Targeted Cell Delivery for Articular Cartilage Regeneration and Osteoarthritis Treatment.

  2019cites this paper
• Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era? Concise Review

  2019cites this paper
• Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis.

  2019cites this paper
• Bone Marrow Mesenchymal Stem Cells Decrease the Expression of RANKL in Collagen-Induced Arthritis Rats via Reducing the Levels of IL-22

  2019cites this paper
• Intraperitoneal infusion of mesenchymal stem cell attenuates severity of collagen antibody induced arthritis

  2018cites this paper
• Use of mesenchymal stem cells in an experimental model of metabolic syndrome complicated with cardiomyopathy

  2018cites this paper
• Immunomodulatory plasticity of mesenchymal stem cells: a potential key to successful solid organ transplantation

  2018cites this paper
• Mechanobiology of mesenchymal stem cells: Which interest for cell-based treatment?

  2017cites this paper
• Periplocoside A ameliorated type II collagen‐induced arthritis in mice via regulation of the balance of Th17/Treg cells

  2017cites this paper
• Etanercept-Synthesising Mesenchymal Stem Cells Efficiently Ameliorate Collagen-Induced Arthritis

  2017cites this paper
• Effect of Cytotoxic T-Lymphocyte-Associated Protein 4 Immunoglobulin (CTLA-4Ig) Fusion Protein on Recruitment of Regulatory T Cells and Macrophages to Dystrophic Muscles in mdx Mouse Model of Duchenne Muscular Dystrophy

  2017cites this paper
• Effects of administration of adipose-derived stromal vascular fraction and platelet-rich plasma to dogs with osteoarthritis of the hip joints.

  2016cites this paper
• Unraveling mechanisms of mesenchymal stromal cell–mediated immunomodulation through patient monitoring and product characterization

  2016cites this paper
• Immunomodulatory properties of mesenchymal stem cell in experimental arthritis in rat and mouse models: A systematic review.

  2016cites this paper
• Mesenchymal stem cells to treat diabetic neuropathy: a long and strenuous way from bench to the clinic

  2016cites this paper
• Allogeneic cell therapy for osteoarthritis

  2016cites this paper
• Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenase

  2016cites this paper
• The preferential homing of mesenchymal stromal cells to sites of inflammation

  2016cites this paper
• Immunomodulation by interleukin-10 overexpressing mesenchymal stem cells for cartilage repair in osteoarthritis

  2015cites this paper
• Viral vector-mediated transgenic cell therapy in regenerative medicine: safety of the process

  2015cites this paper
• The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy

  2015cites this paper
• Homing of mesenchymal stem cells: mechanistic or stochastic? Implications for targeted delivery in arthritis.

  2015cites this paper
• ADMINISTRATION OF ADIPOSE-DERIVED STROMAL VASCULAR FRACTION AND PLATELET RICH PLASMA IN DOGS WITH COXOFEMORAL OSTEOARTHRITIS.

  2015cites this paper
• Mesenchymal Stem Cell-Based Treatment for Microvascular and Secondary Complications of Diabetes Mellitus

  2014cites this paper
• Emerging immunotherapies for rheumatoid arthritis

  2014cites this paper
• Multipotent Mesenchymal Stromal Cells Synergize With Costimulation Blockade in the Inhibition of Immune Responses and the Induction of Foxp3+ Regulatory T Cells

  2014cites this paper